Find clinical trials for Lung Cancer in Cleveland, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near Cleveland, OH, USA:
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung ca...
Phase 2
Cleveland, Ohio, United States and 84 other locations
the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...
Phase 1, Phase 2
Cleveland, Ohio, United States and 30 other locations
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
Cleveland, Ohio, United States and 210 other locations
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
Cleveland, Ohio, United States and 122 other locations
The main aim of this study is to:* evaluate safety and efficacy (per Response Evaluation Criteria in Solid Tumors version 1.1 \[RECIST 1.1\]...
Phase 2
Cleveland, Ohio, United States and 79 other locations
resectable, early-stage non-small cell lung cancer....
Phase 2
Cleveland, Ohio, United States and 96 other locations
combination with pembrolizumab in participants with non-small cell lung cancer (NSCLC).Each treatment cycle lasts 21 days. Particip...
Phase 1, Phase 2
Cleveland, Ohio, United States and 12 other locations
as a single agent and in combination with pembrolizumab in subjects with locally advanced and unresectable or metastatic non-small cell lung ...
Phase 1
Cleveland, Ohio, United States and 18 other locations
This is a multi-center, open-label, Phase 1 clinical study of ZG006 in the US for the treatment of subjects with small cell lung cancer...
Phase 1
Cleveland, Ohio, United States and 5 other locations
overall response rate (ORR) when compared to nivolumab plus PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung...
Phase 2
Cleveland, Ohio, United States and 126 other locations
Clinical trials
Research sites
Resources
Legal